JP2023504733A5 - - Google Patents
Info
- Publication number
- JP2023504733A5 JP2023504733A5 JP2022533579A JP2022533579A JP2023504733A5 JP 2023504733 A5 JP2023504733 A5 JP 2023504733A5 JP 2022533579 A JP2022533579 A JP 2022533579A JP 2022533579 A JP2022533579 A JP 2022533579A JP 2023504733 A5 JP2023504733 A5 JP 2023504733A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- antibody
- chain variable
- variable domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19306583.6 | 2019-12-05 | ||
| EP19306583 | 2019-12-05 | ||
| PCT/EP2020/084770 WO2021110990A1 (en) | 2019-12-05 | 2020-12-04 | Anti-clec-1a antibodies and antigen-binding fragment thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504733A JP2023504733A (ja) | 2023-02-06 |
| JP2023504733A5 true JP2023504733A5 (enExample) | 2023-12-13 |
Family
ID=69232731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533579A Pending JP2023504733A (ja) | 2019-12-05 | 2020-12-04 | 抗ｃｌｅｃ－１ａ抗体及びその抗原結合性断片 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230331852A1 (enExample) |
| EP (1) | EP4069372A1 (enExample) |
| JP (1) | JP2023504733A (enExample) |
| CN (1) | CN115151309A (enExample) |
| CA (1) | CA3159155A1 (enExample) |
| WO (1) | WO2021110990A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240019295A (ko) * | 2021-06-08 | 2024-02-14 | 오제 이뮈노테라프틱스 | 인간화 항-clec-1a 항체 및 이의 항원 결합 단편 및 이의 모방체 |
| US20250026839A1 (en) * | 2021-11-09 | 2025-01-23 | Ose Immunotherapeutics | Identification of CLEC-1 Ligand and Uses Thereof |
| EP4565607A1 (en) * | 2022-08-01 | 2025-06-11 | Ose Immunotherapeutics | Heterodimeric fc-clec-1 fusion molecule and uses thereof |
| WO2025032213A1 (en) * | 2023-08-10 | 2025-02-13 | Ose Immunotherapeutics | Identification of hla-dra as a ligand of clec-1 and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69334275D1 (de) | 1992-08-21 | 2009-05-20 | Univ Bruxelles | Immunoglobuline ohne Leichtkette |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| US11248057B2 (en) * | 2016-03-07 | 2022-02-15 | Vib Vzw | CD20 binding single domain antibodies |
| CA3035262A1 (en) * | 2016-09-16 | 2018-03-22 | Tina Christine Lavranos | Antibody and checkpoint inhibitor combination therapy |
| SMT202100555T1 (it) | 2016-10-21 | 2021-11-12 | Inst Nat Sante Rech Med | Metodi per promuovere la risposta di cellule t |
-
2020
- 2020-12-04 EP EP20819741.8A patent/EP4069372A1/en active Pending
- 2020-12-04 US US17/779,428 patent/US20230331852A1/en not_active Abandoned
- 2020-12-04 CN CN202080095475.7A patent/CN115151309A/zh active Pending
- 2020-12-04 CA CA3159155A patent/CA3159155A1/en active Pending
- 2020-12-04 JP JP2022533579A patent/JP2023504733A/ja active Pending
- 2020-12-04 WO PCT/EP2020/084770 patent/WO2021110990A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018264321B2 (en) | Bispecific recombinant protein and use thereof | |
| TWI899079B (zh) | 抗ror1/抗cd3雙特異性結合分子 | |
| JP7489468B2 (ja) | 二重特異性融合タンパク質及びその応用 | |
| WO2021000530A1 (zh) | 一种双特异性抗体及其制备方法与应用 | |
| JP2021525544A5 (enExample) | ||
| JP7860994B2 (ja) | Ｃｅａｃａｍ５およびｃｄ４７に対する二重特異性抗体 | |
| CN116829186A (zh) | 多特异性抗体及其用途 | |
| WO2022098771A1 (en) | Multispecific antibodies and uses thereof | |
| CN117916272A (zh) | 多特异性抗原结合蛋白 | |
| CN116390755A (zh) | 抗pd-1/cd40双特异性抗体及其用途 | |
| CN106164094A (zh) | 双特异性抗原结合多肽 | |
| WO2023000791A1 (en) | Antibodies against ror1 and uses thereof | |
| JP2025511758A5 (enExample) | ||
| WO2023098785A1 (zh) | 抗4-1bb抗体及其用途 | |
| JP2023504733A (ja) | 抗ｃｌｅｃ－１ａ抗体及びその抗原結合性断片 | |
| CN121293352A (zh) | 抗cmet抗体及使用方法 | |
| CN120530135A (zh) | 抗b7h3抗体和使用方法 | |
| CA3062479A1 (en) | Bispecific recombinant protein and use thereof | |
| IL309107A (en) | Humanized antibodies against CLEC-1A, antigen-binding fragments thereof and their mimetics | |
| CN115151572B (zh) | 针对ror1的抗体及其用途 | |
| TW202428608A (zh) | 抗b7h3抗體以及其使用方法 | |
| WO2024145869A1 (en) | Antibodies against axl and uses thereof | |
| JP2026506070A (ja) | 抗ｃｎｔｎ４抗体及びその使用 | |
| TW202146446A (zh) | 一種抗pd-l1和egfr的四價雙特異性抗體 | |
| HK40078027B (en) | Antibodies against ror1 and uses thereof |